4 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow Recurrent Nasopharyngeal Cancer: new trials by email Literature Review of Recurrent Nasopharyngeal Cancer trials Research Report on Recurrent Nasopharyngeal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy 18F-fludeoxyglucose (18F-FDG), 18F-FPPRGD2 - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 / Phase 2 | Completed | Sanjiv Sam Gambhir | 25 | 2013-03-04 | 2019-10-03 |
| Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer bortezomib, gemcitabine hydrochloride, laboratory biomarker analysis - Recurrent Nasopharyngeal Cancer, Stage IV Nasopharyngeal Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 50 | 2006-08-01 | 2013-01-25 |
| Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas irinotecan hydrochloride, oxaliplatin - Childhood Burkitt Lymphoma, Childhood Central Nervous System Germ Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 24 | 2005-03-01 | 2013-06-05 |
| Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment oxaliplatin - Childhood Central Nervous System Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor | Phase 2 | Completed | National Cancer Institute (NCI) | 180 | 2004-10-01 | 2013-06-05 |
Nasopharyngeal Neoplasms (4) · Colonic Neoplasms (3) · Astrocytoma (2) · Carcinoma, Renal Cell (2) · Familial ependymoma (2) · Neuroblastoma (2) · Neuroectodermal Tumors, Primitive, Peripheral (2) · Optic Nerve Glioma (2) · Osteosarcoma (2) · Rectal Neoplasms (2) · Adrenocortical Carcinoma (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Burkitt Lymphoma (1)
Head and Neck Neoplasms (4) · Nasopharyngeal Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Otorhinolaryngologic Diseases (4) · Otorhinolaryngologic Neoplasms (4) · Pharyngeal Diseases (4) · Pharyngeal Neoplasms (4) · Stomatognathic Diseases (4) · Colonic Diseases (3) · Colorectal Neoplasms (3) · Cranial Nerve Diseases (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Female Urogenital Diseases (3)
Oxaliplatin (2) · Bortezomib (1) · FPP(RGD)2 (1) · Fluorodeoxyglucose F18 (1) · Gemcitabine (1) · Irinotecan (1)
National Cancer Institute (NCI) (3) · Sanjiv Sam Gambhir (1)
United States (4)
Lisa McGregor (1) · Orren Beaty (1) · Sanjiv Gambhir, MD, PhD (1) · Stephen Shibata (1)
PMID 25965900, PMID 26062933, PMID 26611425, PMID 30850872
U01CA097452 (1), U10CA032102 (1), U10CA098543 (1)